Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab.

Seki, R

Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Apr 2010 - 833-841 p. digital

Publication Type: Evaluation Study; Journal Article

1569-8041

10.1093/annonc/mdp481 doi


Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents--administration & dosage
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor--metabolism
Cyclin-Dependent Kinase Inhibitor p27--metabolism
Cyclophosphamide
Doxorubicin
Female
Humans
Lymphoma, Large B-Cell, Diffuse--diagnosis
Male
Middle Aged
Prednisone
Prognosis
Retrospective Studies
Rituximab
S-Phase Kinase-Associated Proteins--metabolism
Survival Analysis
Vincristine
Young Adult